Pamela Contreras Chavez

3.3K posts

Pamela Contreras Chavez banner
Pamela Contreras Chavez

Pamela Contreras Chavez

@PamChMD

Assistant Professor of Hematology 🇵🇪 #IMG #ClassicalHeme🥰 #GlobOnc #MedEd #HemOnc #StoptheClot #WomenInMedicine #Trujillana #LatinaWomeninHeme #hemefan🩸

Chicago, IL Katılım Mayıs 2019
2.5K Takip Edilen3.3K Takipçiler
Pamela Contreras Chavez
Pamela Contreras Chavez@PamChMD·
An honor to contribute with something to this amazing oncology team from Spain lead by Dr Barbacid 🤩✌🏻in order to continue with very hopeful studies for pancreatic cancer cure research. Spread the hope. Donate. Link below in post!!! ⬇️ Increible!!!! @OncoAlert @ASCO
CRIS Contra el Cáncer@criscancer

🔴El Dr. Mariano Barbacid y su equipo, financiados por #CRISContraelCáncer, han logrado curar el cáncer de páncreas en ratones, de forma duradera y sin efectos secundarios. Pero necesitamos tu ayuda para que esto sea una realidad en pacientes. DONA AQUÍ👉ow.ly/b5cA50Y6Ou7

English
0
2
10
1.8K
Karun Neupane, MD
Karun Neupane, MD@KarunNeupaneMD·
🎉My New Year gift for the myeloma community: AllThingsMyeloma™ A free, patient-friendly app, born out of my passion for myeloma & integrating AI in oncology-to help individuals with MGUS/SMM/MM (& caregivers) better understand & manage their journey. ✅iOS & Android
Karun Neupane, MD tweet media
English
5
7
32
5.3K
Diana Franco Betancourt
Diana Franco Betancourt@FrancoBetaDiana·
Happy to share I passed the ABIM Hematology boards 🩸Taking it in my last year of fellowship was a big decision and I’m really glad I did 🙌🏼🎉
Diana Franco Betancourt tweet media
English
3
0
12
402
Pamela Contreras Chavez
Pamela Contreras Chavez@PamChMD·
Board certified hematologist ❤️ Would like to thank all my mentors, 2 of them in these pictures who have been key in the path of becoming a hematologist! Thank you Dr Connors and Dr Langer for showing me the way 🌟 LATINOS in HEMATOLOGY!!! PERU 🇵🇪 presente!!
Pamela Contreras Chavez tweet mediaPamela Contreras Chavez tweet mediaPamela Contreras Chavez tweet mediaPamela Contreras Chavez tweet media
English
6
0
27
1.2K
Ximena Jordan Bruno
Ximena Jordan Bruno@XimeJordan·
Morning from the Winter wonderland ✨😅🙌
Ximena Jordan Bruno tweet mediaXimena Jordan Bruno tweet mediaXimena Jordan Bruno tweet media
English
1
0
13
656
Pamela Contreras Chavez retweetledi
Suhas Gondi
Suhas Gondi@suhas_gondi·
In @NEJM, we discuss the growing fiscal challenges posed by GLP-1s and present a new opportunity for payers to consider: liraglutide. We review the comparative efficacy and argue that this newly generic GLP-1 may better balance access and affordability. nejm.org/doi/full/10.10…
Suhas Gondi tweet mediaSuhas Gondi tweet media
English
0
9
17
7.1K
Chen Zhang, MD, MS, FACP
Chen Zhang, MD, MS, FACP@Dr_CZhang·
#ASH2025 Another wonderful conference and my first oral presentation~ So happy to see my friends, see you next year!!
Chen Zhang, MD, MS, FACP tweet mediaChen Zhang, MD, MS, FACP tweet mediaChen Zhang, MD, MS, FACP tweet mediaChen Zhang, MD, MS, FACP tweet media
English
1
1
4
397
Pamela Contreras Chavez retweetledi
Nishant Rajendra Tiwari
Nishant Rajendra Tiwari@Nischistocyte·
Pre-emptive rituximab stopped relapses in our iTTP patients. 💪 After 3-5 prior relapses each, and 1 exacerbation, 4 patients received scheduled Rituximab for 2 years. Result? No relapses during a median 17.5-month follow-up. (Range 3 - 68 months) This is a big deal for a tough disease. Grateful to my mentor Dr. Khawandanah & our team. More studies needed, but hope is here. Super thankful to all of ours mentor - Dr James N George, truly a difference maker in these patients, and in his mentees careers. The fellows at @StephensonCC continue to shine, we have the best leadership and the fellowship program director (#DrSamiIbrahimi) 🤩 #TTP #iTTP #MedTwitter #HopeInResearch
Nishant Rajendra Tiwari tweet media
English
6
12
44
3.4K
Pamela Contreras Chavez
@allisonoconn As a new attending on my second year of practicing it - It never ends..... I am still learning every single day- the art of Medicine!
English
0
0
1
280
Allison Fitzgerald, MD, PhD
Allison Fitzgerald, MD, PhD@allisonoconn·
My family always gives me crap for still being in “school”. This year at thanksgiving they were genuinely shocked to hear I still had so many new things to learn despite being in “school” for over a decade.
English
5
3
66
9.6K
Pamela Contreras Chavez
Pamela Contreras Chavez@PamChMD·
One of the most challenging consults in the hematology inpatient workflow. -Amazing thread! 🙌🌟
Nishant Rajendra Tiwari@Nischistocyte

My 12-Step Thrombocytopenia Workup 🧵 (Not Medical Advice) 1. Review baseline counts first. Rule out pseudothrombocytopenia. 2. Evaluate for critical conditions: TTP, HIT, or DIC? • Assess heparin exposure - Calculate 4T score. • Peripheral smear for schistocytes. • Check LDH/Haptoglobin/Bilirubin, PT/aPTT/Fibrinogen. 3. Assess for acute leukemia or bone marrow involvement? • Examine peripheral smear for abnormal/neoplastic cells. • Consider imaging if clinically indicated. • Do we need a bone marrow exam? 4. Active life-threatening bleeding? Do we need a platelet transfusion? 5. Review drug-induced thrombocytopenia. Always consult latest literature for implicated medications. 6. Investigate secondary causes: • Nutritional deficiencies: B12, Folate, Copper, Zinc. • Infections: HIV, Hepatitis, CMV, EBV, HSV (clinically guided). • Sepsis leading to DIC. • Endocrine disorders: TSH, Free T4. 7. Review imaging for cirrhosis/splenomegaly. If inconclusive, obtain abdominal ultrasound. 8. Consider mechanical causes: Dialysis/ECMO/IABP/cardiopulmonary bypass/artificial heart valve? 9. Evaluate pregnancy-related disorders: HELLP, AFLP, gestational thrombocytopenia. 10. Assess for autoimmune conditions if clinically warranted. Consider SLE and other rheumatological diseases. 11. Consider rare but serious differentials: • CAPS, other TMA causes, PNH • Post-transfusion purpura, HLH • Pursue only with appropriate clinical suspicion 12. If no clear etiology identified, consider ITP as diagnosis of exclusion. 📋 Key Clinical Considerations: • Critically ill patients frequently have multifactorial thrombocytopenia [A combination of some of the above]. • Primary HLH presenting de novo in adults is exceedingly rare. • Thrombocytopenia with thrombosis: Consider DIC, TTP, HIT, PNH, or VITT. [Image AI Generated] #Hematology #MedTwitter

English
1
1
8
2.1K
Pamela Contreras Chavez
Pamela Contreras Chavez@PamChMD·
Wow!! Join my dear friend @castro_mollo in this amazing #GlobalHematology session!!!!! PERU 🇵🇪 presente 😍🥰 So incredibly proud of you Melanie!!!!!!
Melanie Castro-Mollo@castro_mollo

Add this session to your ASH schedule 📅 on Monday 8th December at 12:30pm at #ASH2025 Very excited to chair this session with amazing colleagues from across Latin America to discuss advances and challenges in leukemia. Looking forward to an inspiring conversation! 🇲🇽🇧🇷🇦🇷🇨🇱🇨🇴🇵🇪

English
0
0
8
1.3K
Pamela Contreras Chavez retweetledi
love(r)
love(r)@lovescritos·
por favor, vayan al psicólogo y dejen de lastimar a personas por tener asuntos pendientes con ustedes mismos. Gracias
Español
16
2.4K
7.5K
229.4K
Pablo Portocarrero
Pablo Portocarrero@portorenal·
Dec 2005: came to the US as a lift operator ⛷️ for seasons in a row so I could pay for med school 🇵🇪. July 2023: I’ll be joining @KUTxpNeph @KUNeph as a Transplant Faculty 🥼. #IMGdreams🥹
Pablo Portocarrero tweet mediaPablo Portocarrero tweet media
English
21
5
182
12.6K
Pamela Contreras Chavez retweetledi
Hemostasis and Thrombosis Research Society
Join HTRS for our upcoming educational webinar: “Novel Therapies in VWD and Rare Bleeding Disorders” on Tuesday, October 21 at 3:00pm EST. Hear from experts and explore the latest advances in treatment and research. Register now to secure your spot! zoom.us/meeting/regist…
Hemostasis and Thrombosis Research Society tweet media
English
0
2
7
876
Pamela Contreras Chavez
Excellent post about our current cancer care situation...and I always think about even worse for rural communities. It bothers me a lot as well.... Sad reality, difficult times.
Vincent Rajkumar@VincentRK

I hear about this. This is not uncommon and it bothers me: Patient has cancer which is getting worse and causing pain Waits days for doctors appointment See the doctor. Scans ordered. But now waits days for an appointment slot to get the scans Scan is done and shows the cancer has worsened. Doctor prescribes new treatment Waits for days as insurance denies new treatment. Peer to peer call needed. Finally, treatment is approved. Waits for days again because chemotherapy appointments are backed up. Finally, the patient receives the treatment. But a month has passed. The cancer has progressed more. All of this with good private insurance. Imagine without. Oncology has advanced rapidly. Our medicines are very specialized. They require a lot of time, expertise, resources. Oncologists are stretched thin. It’s not the type of work that you can easily fill without compromising care. Many patients receive complex chemo and when there is a complication they end up without access to specialized care. We need to expand the oncology work force and limit the burnout that is causing good oncologists to leave patient care for other jobs or retire. There is no question we have made remarkable progress against cancer. And several promising new treatments are on the horizon. Will we have the resources to administer them safely and to all those who need it?

English
0
0
1
875